CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Genome-wide researches and applications on Dendrobium 期刊论文
PLANTA, 2018, 卷号: 248, 期号: 4, 页码: 769-784
作者:  Zheng, Shi-gang;  Hu, Ya-dong;  Zhao, Ruo-xi;  Yan, Shou;  Zhang, Xue-qin
收藏  |  浏览/下载:52/0  |  提交时间:2020/12/24
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文
BREAST CANCER RESEARCH AND TREATMENT, 2018, 卷号: 168, 期号: 2
作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua
收藏  |  浏览/下载:29/0  |  提交时间:2019/12/04
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文
BREAST CANCER RESEARCH AND TREATMENT, 2018, 卷号: 168, 期号: 2
作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua
收藏  |  浏览/下载:55/0  |  提交时间:2019/12/05
The effectiveness and safety of the RESTORE (R) drug-eluting balloon versus a drug-eluting stent for small coronary vessel disease: study protocol for a multi-center, randomized, controlled trial 期刊论文
2018, 卷号: 15, 期号: 7, 页码: 469-475
作者:  Tang, Yi-Da;  Qiao, Shu-Bin;  Su, Xi;  Chen, Yun-Dai;  Jin, Ze-Ning
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文
Breast Cancer Research and Treatment, 2018, 卷号: 168, 期号: 2, 页码: 389-399
作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua
收藏  |  浏览/下载:13/0  |  提交时间:2019/12/27


©版权所有 ©2017 CSpace - Powered by CSpace